1659 related articles for article (PubMed ID: 1084355)
1. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
2. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
Parviainen MT; Savolainen KE; Alhava EM; Mäenpää PH
Ann Clin Res; 1981 Feb; 13(1):26-33. PubMed ID: 6972726
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 1,25-dihydroxyvitamin D3.
Jones G; Byrnes B; Palma F; Segev D; Mazur Y
J Clin Endocrinol Metab; 1980 Apr; 50(4):773-5. PubMed ID: 6965943
[TBL] [Abstract][Full Text] [Related]
5. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin D2 on the assay of 24,25-dihydroxyvitamin D3 in man.
Taylor CM; Wallace JE; Cundy T; Kanis JA
Miner Electrolyte Metab; 1982 Jan; 7(1):15-9. PubMed ID: 6984878
[TBL] [Abstract][Full Text] [Related]
7. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
Swamy N; Dutta A; Ray R
Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
[TBL] [Abstract][Full Text] [Related]
8. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
9. Plasma 24,25-dihydroxyvitamin D3 concentrations in X-linked hypophosphatemic mice: studies using mass fragmentographic and radioreceptor assays.
Cunningham J; Coldwell RD; Jones G; Tenenhouse HS; Trafford DJ; Makin HL
J Bone Miner Res; 1990 Feb; 5(2):173-7. PubMed ID: 2316405
[TBL] [Abstract][Full Text] [Related]
10. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 1 alpha-hydroxyvitamin D2 to activated dihydroxyvitamin D 2 metabolites decreases endogenous 1 alpha, 25-dihydroxyvitamin D 3 in rats and monkeys.
Knutson JC; Hollis BW; LeVan LW; Valliere C; Gould KG; Bishop CW
Endocrinology; 1995 Nov; 136(11):4749-53. PubMed ID: 7588202
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3.
Kimura S; Seino Y; Harada T; Nose O; Yamaoka K; Shimizu K; Tanaka H; Yabuuchi H; Fukui Y; Kamata S
J Pediatr Gastroenterol Nutr; 1988; 7(3):341-6. PubMed ID: 3260278
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of vitamin D metabolites in maternal and umbilical cord blood of Libyan and Norwegian women.
Markestad T; Elzouki A; Legnain M; Ulstein M; Aksnes L
Hum Nutr Clin Nutr; 1984 Jan; 38(1):55-62. PubMed ID: 6607243
[TBL] [Abstract][Full Text] [Related]
14. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
Brown AJ; Ritter CS; Knutson JC; Strugnell SA
Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
[TBL] [Abstract][Full Text] [Related]
15. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.
Bouillon R; Van Assche FA; Van Baelen H; Heyns W; De Moor P
J Clin Invest; 1981 Mar; 67(3):589-96. PubMed ID: 6894152
[TBL] [Abstract][Full Text] [Related]
16. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.
Hughes MR; Baylink DJ; Gonnerman WA; Toverud SU; Ramp WK; Haussler MR
Endocrinology; 1977 Mar; 100(3):799-806. PubMed ID: 233823
[TBL] [Abstract][Full Text] [Related]
17. Changes in the concentrations of vitamin D and its metabolites in the plasma of healthy subjects orally given physiological doses of vitamin D2 by multivitamin or vitamin D preparations.
Matsuoka M; Otsuka H; Masuda S; Okano T; Kobayashi T; Takeuchi T; Itokawa Y
J Nutr Sci Vitaminol (Tokyo); 1989 Aug; 35(4):253-66. PubMed ID: 2585147
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
19. The recognition of 25-hydroxyvitamin D2 and D3 by a new binding protein based 25-hydroxyvitamin D assay.
Su Z; Slay BR; Carr R; Zhu Y
Clin Chim Acta; 2013 Feb; 417():62-6. PubMed ID: 23266769
[TBL] [Abstract][Full Text] [Related]
20. Analysis of vitamin D and its metabolites using thermospray liquid chromatography/mass spectrometry.
Watson D; Setchell KD; Ross R
Biomed Chromatogr; 1991 Jul; 5(4):153-60. PubMed ID: 1655127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
